Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation
Open Access
- 30 March 2009
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 206 (4) , 819-831
Abstract
The molecular mechanisms underlying the development of hepatocellular carcinoma are not fully understood. Liver-specific signal transducer and activator of transcription (STAT) 5A/B–null mice (STAT5-LKO) were treated with carbon tetrachloride (CCl4), and histological analyses revealed liver fibrosis and tumors. Transforming growth factor (TGF)–β levels and STAT3 activity were elevated in liver tissue from STAT5-LKO mice upon CCl4 treatment. To define the molecular link between STAT5 silencing and TGF-β up-regulation, as well as STAT3 activation, we examined STAT5-null mouse embryonic fibroblasts and primary hepatocytes. These cells displayed elevated TGF-β protein levels, whereas messenger RNA levels remained almost unchanged. Protease inhibitor studies revealed that STAT5 deficiency enhanced the stability of mature TGF-β. Immunoprecipitation and immunohistochemistry analyses demonstrated that STAT5, through its N-terminal sequences, could bind to TGF-β and that retroviral-mediated overexpression of STAT5 decreased TGF-β levels. To confirm the in vivo significance of the N-terminal domain of STAT5, we treated mice that expressed STAT5 lacking the N terminus (STAT5-ΔN) with CCl4. STAT5-ΔN mice developed CCl4-induced liver fibrosis but no tumors. In conclusion, loss of STAT5 results in elevated TGF-β levels and enhanced growth hormone–induced STAT3 activity. We propose that a deregulated STAT5–TGF-β–STAT3 network contributes to the development of chronic liver disease.Keywords
This publication has 55 references indexed in Scilit:
- Genomic dissection of the cytokine-controlled STAT5 signaling network in liverPhysiological Genomics, 2008
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008
- Disruption of the latent transforming growth factor-β binding protein-1 gene causes alteration in facial structure and influences TGF-β bioavailabilityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage outputExperimental Hematology, 2007
- Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel STAT5b Gene MutationPediatrics, 2006
- Signal Transducers and Activators of Transcription 5b Activation Enhances Hepatocellular Carcinoma Aggressiveness through Induction of Epithelial-Mesenchymal TransitionCancer Research, 2006
- Signalling cross-talk between hepatocyte nuclear factor 4α and growth-hormone-activated STAT5bBiochemical Journal, 2006
- EGFR is phosphorylated at Ty845 in hepatocellular carcinomaLaboratory Investigation, 2006
- Transforming growth factor β (TGF-β) expression in isolated and cultured rat hepatocytesJournal of Cellular Physiology, 1996
- Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosisJournal of Hepatology, 1994